Albert Labs International Corp.
ABRT
CNSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.70M | -2.10M | -2.72M | -5.46M | -5.16M |
| Total Depreciation and Amortization | 12.60K | 9.30K | 7.20K | 2.90K | 5.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.54M | 1.75M | 2.53M | 4.76M | 3.40M |
| Change in Net Operating Assets | -224.40K | -219.10K | -790.20K | -410.30K | 676.40K |
| Cash from Operations | -378.80K | -560.40K | -974.90K | -1.11M | -1.07M |
| Capital Expenditure | 14.80K | 14.80K | -48.10K | -51.30K | -88.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -9.20K | -9.20K | -9.20K | -9.20K |
| Cash from Investing | 14.80K | 5.60K | -57.30K | -60.50K | -98.00K |
| Total Debt Issued | 10.00K | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 340.10K | 340.10K | 373.00K | 1.51M | 1.82M |
| Repurchase of Common Stock | -9.60K | -9.60K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 251.50K | 244.10K | 277.00K | 1.19M | 1.44M |
| Foreign Exchange rate Adjustments | 34.30K | 29.90K | -2.10K | -2.10K | -36.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.20K | -280.90K | -757.40K | 13.60K | 229.20K |
